DAiNA Opens State-of-the-Art Labs in Zurich’s Bio-Technopark

DAiNA has opened new laboratories in the Bio-Technopark Schlieren, Zurich - one of Switzerland’s premier biotech hubs, alongside ETH Zurich, the University of Zurich, and leading pharma companies.

The facilities are purpose-built for advanced molecular biology, cell culture, and imaging, and are certified for BSL-1 and BSL-2 research by Swiss authorities. They include secure infrastructure for the storage of human cancer samples, spheroid and organoid cultures, and support research into tumor evolution and treatment response. Long-term sample safety is ensured by backup systems in a flood-protected, alarm-secured basement with liquid nitrogen tanks and -80°C freezers.

DAiNA collaborates closely with DiNAMIQS, a GMP-certified biologics manufacturer, and DiNABIOS, a pioneer in 3D tissue culture and real-time imaging through its DiNACUBE platform - both located within the same park.

With cutting-edge infrastructure and integrated partnerships, DAiNA is positioned to drive breakthroughs in personalized cancer research and therapy development.